晚期患者鞘内注射生长抑素。两例报告。
Intrathecal somatostatin in terminally ill patients. A report of two cases.
作者信息
Meynadier J, Chrubasik J, Dubar M, Wünsch E
机构信息
Department of Anaesthesia, Centre Oscar Lambret, 59020 LilleFrance Department of Anaesthesia, University Hospital, FreiburgF.R.G. Max Planck Institute of Biochemistry, MunichF.R.G.
出版信息
Pain. 1985 Sep;23(1):9-12. doi: 10.1016/0304-3959(85)90224-6.
Intrathecal morphine has been shown to be reliable in producing analgesia in patients with intractable cancer pain. Recently, we have demonstrated that intrathecal somatostatin is as effective in the treatment of cancer pain as intrathecal morphine. This report presents 2 cases in whom analgesia could be maintained for 60 and 25 days, respectively, under continuous intrathecal infusion of somatostatin by means of infusion devices.
鞘内注射吗啡已被证明在治疗顽固性癌痛患者时能可靠地产生镇痛效果。最近，我们已经证明鞘内注射生长抑素在治疗癌痛方面与鞘内注射吗啡一样有效。本报告介绍了2例患者，通过输注装置持续鞘内输注生长抑素，镇痛效果分别维持了60天和25天。
Zotero 插件